Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.310 GeneticVariation disease BEFREE However, Ras mutational analysis demonstrated that only one of the tumors in this series, an oncocytic carcinoma with a balanced karyotype, had activating Ras mutations (at codon 13 of K-Ras). 10334566 1999
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.310 GeneticVariation disease BEFREE In this study, a group of 60 follicular thyroid neoplasms [18 FTC, 1 Hurthle cell carcinoma (HCC), 24 follicular thyroid adenomas (FTA), 5 Hurthle cell adenomas (HCA), and 12 follicular variants of papillary thyroid carcinomas (FV-PTC)] were analyzed to determine the prevalence of the PAX8-PPARG translocation by fluorescence in situ hybridization. 19963130 2010
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.310 Biomarker disease BEFREE The Bcl-2(+) phenotype was associated with improved relapse-free survival (P = 0.04) and disease-specific survival (P = 0.01) in widely invasive carcinomas and the Ki-67(+)/Bcl-2(-) phenotype was associated with the diagnosis of widely invasive Hürthle cell carcinoma (P < 0.001). 11786411 2002
Entrez Id: 5727
Gene Symbol: PTCH1
PTCH1
0.030 AlteredExpression disease BEFREE Forty-seven percent (16 of 34) of papillary carcinomas and one oncocytic carcinoma expressed high RET/PTC1 mRNA levels. 16595592 2006
Entrez Id: 5727
Gene Symbol: PTCH1
PTCH1
0.030 AlteredExpression disease BEFREE CCI = Charlson Comorbidity Index; CCR = California Cancer Registry; CI = confidence interval; DTC = differentiated thyroid cancer; FTC = follicular thyroid carcinoma; HCC = Hürthle cell carcinoma; IQR = interquartile range; mPTC = papillary thyroid micro-carcinoma; OR = odds ratio; OSPHD = Office of Statewide Health Planning and Development; PTC = papillary thyroid carcinoma. 28816539 2017
Entrez Id: 5979
Gene Symbol: RET
RET
0.030 AlteredExpression disease BEFREE Forty-seven percent (16 of 34) of papillary carcinomas and one oncocytic carcinoma expressed high RET/PTC1 mRNA levels. 16595592 2006
Entrez Id: 5727
Gene Symbol: PTCH1
PTCH1
0.030 Biomarker disease BEFREE RNA was isolated from multinodular goiter (MNG; n=6), papillary carcinoma (PTC, n=14), follicular carcinoma (FC; n=5), and Hürthle cell carcinoma (HCC; n=7). 24559275 2014
Entrez Id: 5979
Gene Symbol: RET
RET
0.030 AlteredExpression disease BEFREE CCI = Charlson Comorbidity Index; CCR = California Cancer Registry; CI = confidence interval; DTC = differentiated thyroid cancer; FTC = follicular thyroid carcinoma; HCC = Hürthle cell carcinoma; IQR = interquartile range; mPTC = papillary thyroid micro-carcinoma; OR = odds ratio; OSPHD = Office of Statewide Health Planning and Development; PTC = papillary thyroid carcinoma. 28816539 2017
Entrez Id: 5979
Gene Symbol: RET
RET
0.030 Biomarker disease BEFREE RNA was isolated from multinodular goiter (MNG; n=6), papillary carcinoma (PTC, n=14), follicular carcinoma (FC; n=5), and Hürthle cell carcinoma (HCC; n=7). 24559275 2014
Entrez Id: 2158
Gene Symbol: F9
F9
0.020 Biomarker disease BEFREE RNA was isolated from multinodular goiter (MNG; n=6), papillary carcinoma (PTC, n=14), follicular carcinoma (FC; n=5), and Hürthle cell carcinoma (HCC; n=7). 24559275 2014
Entrez Id: 367
Gene Symbol: AR
AR
0.020 AlteredExpression disease BEFREE We showed the aberrant expression of AR in mucoepidermoid and oncocytic carcinoma, a strong relation between cytoplasmic ERβ expression and tumor grade, and a strong correlation between nuclear GPR30 expression and disease-free survival (DFS) of SGT patients. 29385707 2018
Entrez Id: 5726
Gene Symbol: TAS2R38
TAS2R38
0.020 AlteredExpression disease BEFREE CCI = Charlson Comorbidity Index; CCR = California Cancer Registry; CI = confidence interval; DTC = differentiated thyroid cancer; FTC = follicular thyroid carcinoma; HCC = Hürthle cell carcinoma; IQR = interquartile range; mPTC = papillary thyroid micro-carcinoma; OR = odds ratio; OSPHD = Office of Statewide Health Planning and Development; PTC = papillary thyroid carcinoma. 28816539 2017
Entrez Id: 2158
Gene Symbol: F9
F9
0.020 AlteredExpression disease BEFREE CCI = Charlson Comorbidity Index; CCR = California Cancer Registry; CI = confidence interval; DTC = differentiated thyroid cancer; FTC = follicular thyroid carcinoma; HCC = Hürthle cell carcinoma; IQR = interquartile range; mPTC = papillary thyroid micro-carcinoma; OR = odds ratio; OSPHD = Office of Statewide Health Planning and Development; PTC = papillary thyroid carcinoma. 28816539 2017
Entrez Id: 8030
Gene Symbol: CCDC6
CCDC6
0.020 Biomarker disease BEFREE RNA was isolated from multinodular goiter (MNG; n=6), papillary carcinoma (PTC, n=14), follicular carcinoma (FC; n=5), and Hürthle cell carcinoma (HCC; n=7). 24559275 2014
Entrez Id: 5726
Gene Symbol: TAS2R38
TAS2R38
0.020 Biomarker disease BEFREE RNA was isolated from multinodular goiter (MNG; n=6), papillary carcinoma (PTC, n=14), follicular carcinoma (FC; n=5), and Hürthle cell carcinoma (HCC; n=7). 24559275 2014
Entrez Id: 367
Gene Symbol: AR
AR
0.020 Biomarker disease BEFREE In addition, it reemphasizes the importance of androgen receptor in differential diagnosis from its mimics like oncocytic carcinoma and oncocytic variant of mucoepidermoid carcinoma. 31495607 2019
Entrez Id: 8030
Gene Symbol: CCDC6
CCDC6
0.020 AlteredExpression disease BEFREE CCI = Charlson Comorbidity Index; CCR = California Cancer Registry; CI = confidence interval; DTC = differentiated thyroid cancer; FTC = follicular thyroid carcinoma; HCC = Hürthle cell carcinoma; IQR = interquartile range; mPTC = papillary thyroid micro-carcinoma; OR = odds ratio; OSPHD = Office of Statewide Health Planning and Development; PTC = papillary thyroid carcinoma. 28816539 2017
Entrez Id: 1964
Gene Symbol: EIF1AX
EIF1AX
0.010 GeneticVariation disease BEFREE We report an EIF1AX mutation in a patient found to have Hürthle cell carcinoma. 28965201 2018
Entrez Id: 7253
Gene Symbol: TSHR
TSHR
0.010 GeneticVariation disease BEFREE The TSHR mutation in this Hürthle cell carcinoma may be responsible for maintaining differentiated thyroid function and hyperthyroidism. 10037070 1999
Entrez Id: 7849
Gene Symbol: PAX8
PAX8
0.010 GeneticVariation disease BEFREE In this study, a group of 60 follicular thyroid neoplasms [18 FTC, 1 Hurthle cell carcinoma (HCC), 24 follicular thyroid adenomas (FTA), 5 Hurthle cell adenomas (HCA), and 12 follicular variants of papillary thyroid carcinomas (FV-PTC)] were analyzed to determine the prevalence of the PAX8-PPARG translocation by fluorescence in situ hybridization. 19963130 2010
Entrez Id: 9474
Gene Symbol: ATG5
ATG5
0.010 Biomarker disease BEFREE Remarkably, inhibition of autophagosome formation by Atg5 silencing or treatment with pharmacological inhibitors of autophagosome formation restored ciliogenesis in the Hürthle cell carcinoma cell line XTC.UC1 which exhibits a high basal autophagic flux. 27816963 2016
Entrez Id: 84816
Gene Symbol: RTN4IP1
RTN4IP1
0.010 Biomarker disease BEFREE In 3 thyroid cancer cell lines (TPC1 from a papillary thyroid cancer, FTC133 from a follicular thyroid cancer, XTC1 from a Hürthle cell carcinoma), small interfering RNA knockdown of RTN4IP1 was used to determine its role in regulating the hallmarks of malignant cell phenotype (cellular proliferation, migration, apoptosis, invasion, tumor spheroid formation, anchorage independent growth). 23393170 2013
Entrez Id: 4535
Gene Symbol: ND1
ND1
0.010 GeneticVariation disease BEFREE In the oncocytic carcinoma, a large deletion in the mitochondrial-DNA-encoded MTND1 was found, associated with respiratory complex I disassembly, which was subsequently shown to be a constitutional, de novo genetic lesion. 21926107 2011
Entrez Id: 10752
Gene Symbol: CHL1
CHL1
0.010 AlteredExpression disease BEFREE CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules. 30311656 2018
Entrez Id: 2145
Gene Symbol: EZH1
EZH1
0.010 GeneticVariation disease BEFREE EZH1 mutations were detected in 3% of follicular adenoma and in 20% of Hürthle cell adenoma, and one minimally invasive Hürthle cell carcinoma. 29723601 2018